Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis

Overview of attention for article published in JAMA: Journal of the American Medical Association, August 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 21 news outlets
blogs: 4 blogs
twitter: 496 X users
facebook: 3 Facebook pages
reddit: 2 Redditors

video: 1 YouTube creator
guideline: 3 clinical guideline sources
bluesky: 9 Bluesky users
podcasts: 8 podcasts

Readers on

mendeley: 241 Mendeley

So far, Altmetric has seen 10 Bluesky posts from 9 Bluesky users, with an upper bound of 31,310 followers.

BLING III trial- continuous infusion of pip-tazo or meropenem did not significantly reduce 90-day mortality but improved clinical cure rates in critically ill patients with sepsis jamanetwork.com/journals/jam... #OTILT @bwdionne.bsky.social @jeffpea…

Is there a recording of the @criticalcarereviews.com session on BLING III? Does anyone know if a Bayesian re-analysis and/or an individual patient meta-analysis of all the different continuous infusion trials is planned?

Most Viewed JAMA 2024: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With #Sepsis 🔗 ja.ma/3ZY9n8I

5. BLING3 trial jamanetwork.com/journals/jam... WHY Practice-changing IMPLICATIONS In critically ill adults treated with b-lactams for sepsis, antibiotics should be administered by continuous infusion wherever possible Unclear if this applies to chi…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 6 additional Bluesky posts.